Skip to Main Content

1,085

Views

0

CrossRef citations to date

0

Altmetric

Case Report

A rare case of parental iron-induced persistent hypophosphatemia

Abigayle Sullivana Department of Internal Medicine, Reading Hospital – Tower Health System, Reading, PA, USACorrespondence[email protected]

https://orcid.org/0000-0002-0876-8132

,

Theresa Lanhama Department of Internal Medicine, Reading Hospital – Tower Health System, Reading, PA, USA

https://orcid.org/0000-0002-7725-3634

&

Adam Rubinb Department of Nephrology, Reading Hospital – Tower Health System, Reading, PA, USA

References

Schaefer, Benedikt et al. “Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk.” PloS onevol. 11,12 e0167146. 1 Dec. 2016, doi:10.1371/journal.pone.0167146.
Google Scholar
Anand G, Schmid C. Severe hypophosphataemia after intravenous iron administration. BMJ Case Rep [Internet]. 2017 Mar 13 [cited 2019 Nov 10];2017:bcr2016219160.
Google Scholar
Coffman TM, Schrier RW. Schrier’s diseases of the kidney. [Electronic resource] [Internet]. Philadelphia, PA, USA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2013 [cited 2020 Jan 3].
Google Scholar
Fang W (1,2), Bloom S (1,2), Garg M (1,2), et al. Symptomatic severe hypophosphatemia after intravenous ferric carboxymaltose. JGH Open [Internet]. 2019 Nov 10;3(5):438–440.
Google Scholar
Shimizu Y (1), Okamoto T (1), Suzuki H (1), et al. Hypophosphatemia induced by intravenous administration of saccharated ferric oxide. Another form of FGF23-related hypophosphatemia. Bone [Internet]. 2019 Nov 10;45(4):814–816.
Google Scholar